Intercontinental circulation of human influenza A(H1N2) reassortant viruses during the 2001-2002 influenza season.
Reassortant influenza A viruses bearing the H1 subtype of hemagglutinin (HA) and the N2 subtype of neuraminidase (NA) were isolated from humans in the United States, Canada, Singapore, Malaysia, India, Oman, Egypt, and several countries in Europe during the 2001-2002 influenza season. The HAs of these H1N2 viruses were similar to that of the A/New Caledonia/20/99(H1N1) vaccine strain both antigenically and genetically, and the NAs were antigenically and genetically related to those of recent human H3N2 reference strains, such as A/Moscow/10/99(H3N2). All 6 internal genes of the H1N2 reassortants examined originated from an H3N2 virus. This article documents the first widespread circulation of H1N2 reassortants on 4 continents. The current influenza vaccine is expected to provide good protection against H1N2 viruses, because it contains the A/New Caledonia/20/99(H1N1) and A/Moscow/10/99(H3N2)-like viruses, which have H1 and N2 antigens that are similar to those of recent H1N2 viruses.
Xu
Xiyan
X
Influenza Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. xxu@cdc.gov
Smith
Catherine B
CB
Mungall
Bruce A
BA
Lindstrom
Stephen E
SE
Hall
Henrietta E
HE
Subbarao
Kanta
K
Cox
Nancy J
NJ
Klimov
Alexander
A
D000956:Antigens, Viral / Q000032:analysis; D006388:Hemagglutinins / Q000032:analysis / Q000145:classification; D006801:Humans; D009980:Influenza A virus / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000502:physiology*; D007251:Influenza, Human / Q000453:epidemiology / Q000821:virology*; D009439:Neuraminidase / Q000235:genetics; D016865:Reassortant Viruses / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000502:physiology*
D000956:Antigens, Viral; D006388:Hemagglutinins; D009439:Neuraminidase